294 related articles for article (PubMed ID: 30720192)
1. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
Jingjing H; Rui J; Hui P
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis.
Yi L; Zhang H; Zou J; Luo P; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):612-619. PubMed ID: 29530332
[TBL] [Abstract][Full Text] [Related]
3. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Forsse D; Berg HF; Bozickovic O; Engerud H; Halle MK; Hoivik EA; Woie K; Werner HMJ; Haldorsen IS; Trovik J; Krakstad C
Gynecol Oncol; 2021 Feb; 160(2):396-404. PubMed ID: 33317908
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract][Full Text] [Related]
5. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
Guo Q; Wang R; Jin D; Yin Z; Hu B; Li R; Wu D
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):15-23. PubMed ID: 35181028
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
[TBL] [Abstract][Full Text] [Related]
8. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis.
Ao M; Ding T; Tang D; Xi M
Med Sci Monit; 2020 Sep; 26():e925595. PubMed ID: 32950998
[TBL] [Abstract][Full Text] [Related]
10. Toxicity after adjuvant therapy for stage III uterine cancer.
Chen LC; Huang Y; Hou JY; Khoury-Collado F; Melamed A; St Clair CM; Tergas AI; Hur C; Hillyer GC; Hershman DL; Wright JD
Gynecol Oncol; 2020 Dec; 159(3):737-743. PubMed ID: 33008633
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Mar; (3):CD003916. PubMed ID: 22419290
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
Kong A; Johnson N; Kitchener HC; Lawrie TA
J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy in stage III endometrial cancer confined to the pelvis.
Albeesh R; Turgeon GA; Alfieri J; Mansure JJ; Fu L; Arseneau J; Zeng X; Jardon K; Gilbert L; Souhami L
Gynecol Oncol; 2019 Jan; 152(1):26-30. PubMed ID: 30473258
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis.
Winarto H; Ibrahim NAA; Putri YM; Adnan FDSF; Safitri ED
PeerJ; 2022; 10():e14420. PubMed ID: 36438578
[TBL] [Abstract][Full Text] [Related]
16. Postoperative chemoradiotherapy versus radiotherapy alone for cervical cancer: A systematic review and meta-analysis.
Yang J; Yin J; Yan G; Huang D; Wang J
J Obstet Gynaecol; 2016 Jul; 36(5):641-8. PubMed ID: 26821995
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
[TBL] [Abstract][Full Text] [Related]
18. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
20. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.
Lum MM; Belnap TW; Frandsen J; Brown AP; Sause WT; Soisson AP; Dodson MK; Werner T; Gaffney DK
Am J Clin Oncol; 2015 Jun; 38(3):283-8. PubMed ID: 23774072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]